HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$7.11
Day range
$6.68 - $7.20
Year range
$3.26 - $9.18
Market cap
413.19M USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.45M | 5.34% |
Net income | -22.37M | -3.93% |
Net profit margin | — | — |
Earnings per share | -0.30 | 3.23% |
EBITDA | -25.36M | -5.33% |
Effective tax rate | -0.44% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 240.65M | -19.11% |
Total assets | 246.77M | -18.10% |
Total liabilities | 10.05M | -26.14% |
Total equity | 236.72M | — |
Shares outstanding | 64.68M | — |
Price to book | 1.94 | — |
Return on assets | -24.69% | — |
Return on capital | -25.80% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -22.37M | -3.93% |
Cash from operations | -22.80M | -58.52% |
Cash from investing | 8.00M | -71.37% |
Cash from financing | — | — |
Net change in cash | -14.83M | -136.06% |
Free cash flow | -15.86M | -115.48% |
About
Founded
2016
Headquarters
Website
Employees
66